Target intelligence / Profile preview

CD200 receptor 1 like (CD200R1L)

Target
CD200R1L
Molecular classification
Receptor, Immunoglobulin superfamily, Cell surface glycoprotein, Single-pass membrane protein
01

Overview

CD200 receptor 1 like (CD200R1L) is a member of the CD200 receptor family and encodes a cell surface transmembrane glycoprotein receptor structurally related to the inhibitory receptor CD200R1, but functions as an activating receptor mainly on human neutrophils[2][3][4][5]. Unlike CD200R1, which suppresses immune activity, CD200R1L enhances cellular activation, driving immune responses such as reactive oxygen species production via Syk, PI3Kβ, PI3Kδ, and Rac GTPase signaling pathways[2]. The receptor is evolutionarily conserved among vertebrates and is believed to provide rapid immunological responses to pathogens, reflecting a process of convergent evolution in host defense[2]. While it shares high sequence similarity with CD200R1, CD200R1L does not bind the CD200 ligand, highlighting structural adaptation for its activating role[3]. CD200R1L is predicted to be involved in regulation of neuroinflammatory responses as well[5]. No drugs are approved to specifically target CD200R1L and it is not currently in clinical use, but its unique immunostimulatory function makes it a theoretical candidate for modulation in infectious diseases and autoimmunity research.

Other names
CD200 receptor 1 likeCell surface glycoprotein CD200 receptor 2CD200R2CD200 receptor-like 2CD200RLaCD200 cell surface glycoprotein receptor-like 2CD200 cell surface glycoprotein receptor-like aCell surface glycoprotein CD200 receptor 1-likeCell surface glycoprotein OX2 receptor 2HuCD200R2cell surface glycoprotein CD200 receptor 2CD200 cell surface glycoprotein receptor 2CD200 receptor 2cell surface glycoprotein CD200 receptor 1-likecell surface glycoprotein OX2 receptor 2MO2R2
02

Mechanism of action

Activation of signaling via Syk, PI3Kβ, PI3Kδ, and Rac GTPase in neutrophils[2]

03

Biological functions

Immune response modulation (activating receptor)Regulation of reactive oxygen species (ROS) production in neutrophilsSignal transductionRegulation of neuroinflammatory response
04

Disease associations

InflammationInfection (host-pathogen interaction/adaptive immunity)Potential involvement in immune-related diseases (based on related family functions)
05

Safety considerations

theoretical risks may include excessive neutrophil activation or autoimmunity, but no evidence is yet documented[2]

Beyond the preview

Go deeper on CD200 receptor 1 like (CD200R1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD200 receptor 1 like (CD200R1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call